Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Open in API
Filings indexed 1,765 across all filing types
Latest filing 2021-10-26 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
Financial Result Updates
Interim / Quarterly Report Classification · 95% confidence The document is a detailed communication addressed to stock exchanges (BSE and NSE) regarding the approval and submission of audited standalone financial results and unaudited consolidated financial results for the quarter and half year ended 30th September 2021. It includes an independent auditor's report on the standalone quarterly financial results and year-to-date results, prepared under SEBI Listing Regulations. The document contains detailed financial data, auditor's opinion, management responsibilities, and financial statements for the specified period. The presence of an auditor's report and comprehensive financial results for a period shorter than a full fiscal year (quarter and half year) indicates this is an Interim / Quarterly Report. It is not merely an announcement or a certification but contains substantive financial data and analysis. Therefore, the appropriate classification is Interim / Quarterly Report (IR). H1 2022
2021-10-26 English
Intimation of Loss of Share Certificate
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) regarding the loss of share certificates by shareholders. It references Regulation 39 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to the handling of lost or misplaced share certificates. The content includes details of the lost certificates and a request to trading members to refrain from trading these shares until duplicates are issued. There is no financial data, earnings information, or report attached or referenced as being published. The document is an official regulatory communication about share certificate loss, which fits best under Regulatory Filings (RNS) as it is a compliance-related announcement that does not fit other specific categories.
2021-10-20 English
Loss of Share Certificates
Regulatory Filings
2021-10-20 English
In furtherance to our letter dated 11-Oct-21 on the captioned subject, we would like to inform that the teleconference with Investors / Analyst has been rescheduled to 06:30 P.M. from 06:00 ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding a rescheduling of a teleconference (conference call) with investors and analysts to discuss the company's quarterly and half-year financial performance. It references the financial results for the quarter and half year ended 30th September 2021 but does not contain any financial data or detailed discussion of results itself. The document is short (1412 characters) and serves as an announcement about the timing of a conference call rather than the call transcript or financial report. Therefore, it is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement related to investor communications but not the actual call transcript or financial report.
2021-10-16 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing about the rescheduling of a teleconference (conference call) with investors and analysts to discuss the financial performance for the quarter and half year ended 30th September 2021. It does not contain any financial data or results itself, but rather is an announcement about the timing of a conference call. The content matches the description of a Call Transcript (CT) announcement or a notice related to a conference call. However, since it is only a notice of the call and not the transcript itself, it is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement that does not fit other categories. The document length is short (1412 characters), and it is not a report or transcript but an announcement of a call schedule change.
2021-10-16 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 90% confidence The document is a letter addressed to stock exchanges (BSE and NSE) informing them about a scheduled teleconference (conference call) with investors and analysts to discuss the financial performance for the quarter and half year ended 30th September 2021. It provides dial-in details for the call but does not contain any financial data or results itself. The document is essentially an announcement of a conference call event rather than the transcript or financial report. Therefore, the appropriate classification is a Call Transcript (CT) category, as it relates to a conference call, but since this is only a notice of the call and not the transcript, the best fit is still CT as it is the closest category for conference call related documents. Confidence is high due to clear mention of conference call and financial period referenced.
2021-10-11 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.